February 16, 2011
Johnson & Johnson has recalled about 70,000 syringes of an injectable formulation of the antipsychotic Invega after discovering cracks in the syringes, which could potentially lead to infections or reduced efficacy in users.
J&J, which has issued a series of recalls of various products due to manufacturing-quality problems since 2009, sent notice of the recall of Invega Sustenna to distributors, pharmacists and health-care providers on Feb. 11, according to a company website. The recall affects products sold in the U.S., Australia, Canada and South Korea.
The recalled syringes contain 234-milligram dosages of Invega Sustenna, which were distributed beginning in March 2010. Other dosage strengths of the drug aren’t being recalled.